RPRX fund manager activity
Royalty Pharma plc · Nasdaq. Reported by 6 tracked fund managers in their 13F filings, Q2 2020 to Q2 2026.
Q2 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Pat Dorsey - Dorsey Asset Management | Added | 2,456,528 | $137,737,525 | 8.82% | Aug 14, 2026 |
| Samantha McLemore - Patient Capital Management | Trimmed | 3,598,808 | $201,785,166 | 6.70% | Aug 13, 2026 |
| Torray Funds | Trimmed | 602,028 | $33,755,710 | 4.55% | Jul 30, 2026 |
Q1 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Pat Dorsey - Dorsey Asset Management | Added | 2,276,570 | $109,207,063 | 8.70% | May 15, 2026 |
| Samantha McLemore - Patient Capital Management | Added | 3,643,716 | $174,789,053 | 6.52% | May 14, 2026 |
| Torray Funds | Trimmed | 645,425 | $30,961,051 | 4.54% | May 1, 2026 |
Older quarters